| Dr Robert I Massey, MD | |
|
1850 Town Center Parkway, Reston Hospital Center, Reston, VA 20190 | |
| (703) 471-0919 | |
| (703) 742-9081 |
| Full Name | Dr Robert I Massey |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1850 Town Center Parkway, Reston, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851370738 | NPI | - | NPPES |
| 173386 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101055441 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert I Massey, MD Po Box 2757, Reston, VA 20195 Ph: (703) 471-0919 | Dr Robert I Massey, MD 1850 Town Center Parkway, Reston Hospital Center, Reston, VA 20190 Ph: (703) 471-0919 |
News Archive
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
Medflow, Inc., the leading electronic health record (EHR) and practice management solutions provider for ophthalmologists, announced today the availability of Medflow 2.0 EHR, its most advanced cloud-based EHR system. Medflow 2.0 EHR streamlines the entire workflow, providing logic and guidelines to increase speed of data entry, while also satisfying regulatory requirements.
The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, announced Eli Lilly and Company (NYSE: LLY).
Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.
› Verified 3 days ago
Dr. James L Torrens, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1850 Town Center Pkwy, Reston Hospital Center, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-742-9081 | |
Jill Bekezela Sagonda-guerrero, MD, MPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9000 | |
Charles Dougherty, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-471-0919 | |
Dr. David Lee Nadler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9051 | |
Dr. Richard G Hetherington, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Resotn Hospital Center, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-741-9081 | |
Dr. Herbert W Fingerhut, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-742-9081 | |
Sami Badri, M.D. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9000 |